4//SEC Filing
Chu Chung K. 4
Accession 0000899243-20-030324
CIK 0001593899other
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 8:05 PM ET
Size
11.4 KB
Accession
0000899243-20-030324
Insider Transaction Report
Form 4
Chu Chung K.
10% Owner
Transactions
- Conversion
Series A Convertible Preferred Stock
2020-11-03−100,000→ 0 total→ Common Stock (100,000 underlying) - Conversion
Series C Convertible Preferred Stock
2020-11-03−43,859→ 0 total→ Common Stock (43,859 underlying) - Conversion
Series B Convertible Preferred Stock
2020-11-03−33,003→ 0 total→ Common Stock (33,003 underlying) - Conversion
Common Stock
2020-11-03+176,862→ 1,176,862 total
Footnotes (1)
- [F1]The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.
Documents
Issuer
Atea Pharmaceuticals, Inc.
CIK 0001593899
Entity typeother
Related Parties
1- filerCIK 0001830163
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 7:00 PM ET
- Accepted
- Nov 3, 8:05 PM ET
- Size
- 11.4 KB